25 June 2008
"Mediwatch has signed an agreement with Bostwick Laboratories Inc. a general reference laboratory headquartered in Richmond, Virginia,USA) granting it sole rights to sell the nucleic acid amplification based PCA3PlusTM test worldwide, with the exception of Canada and the USA."
It must also be noted that there are other companies that offer the PCA3 test under their own brand name.
Beyond the Abstract - Prostate Cancer Gene 3 (PCA3): Development and Internal Validation of a Novel Biopsy Nomogram
Wednesday, 24 June 2009
BERKELEY, CA (UroToday.com) - In this paper, we investigated 809 prostate cancer patients subjected to >10 cores at initial or repeat prostate biopsy from two prospective, multi-center studies from Europe and North America.
Login to read more...
Main Website
The Prevalence of Erectile Dysfunction Among Brazilian Men Screened for Prostate Cancer - Abstract
Of men screened for prostate cancer in Brazil, approximately 40% have moderate or severe ED. Severe LUTS, higher HRQL scores, a large prostate volume, a low BMI and higher PSA levels might be associated with higher rates of ED. These variables should be considered when analysing the erectile function of patients screened for prostate cancer.
Written by:
Paranhos M, Antunes A, Andrade E, Freire G, Srougi M.
Link to Article
No comments:
Post a Comment